Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4
Glucocorticoids are potent endogenous anti-inflammatory molecules, and their cognate receptor, glucocorticoid receptor (GR), is expressed in nearly all immune cells. Macrophages are heterogeneous immune cells having a central role in both tissue homeostasis and inflammation and also play a role in the pathogenesis of some inflammatory diseases. Paradoxically, glucocorticoids have only a limited efficacy in controlling the resolution of these macrophage-related diseases. Here, we report that the transcriptomes of monocyte-like THP-1 cells and macrophage-like THP-1 cells (THP1-MΦ) have largely conserved gene expression patterns. In contrast, the differentiation to THP1-MΦ significantly altered the sensitivity of gene transcription to glucocorticoids. Among glucocorticoid-regulated genes, we identified the exopeptidase dipeptidyl peptidase-4 (DPP4) as a critical glucocorticoid-responsive gene in THP1-MΦ. We found that GR directly induces DPP4 gene expression by binding to two glucocorticoid-responsive elements (GREs) within the DPP4 promoter. Additionally, we show that glucocorticoid-induced DPP4 expression is blocked by the GR antagonist RU-486 and by GR siRNA transfection and that DPP4 enzyme activity is reduced by DPP4 inhibitors. Of note, glucocorticoids highly stimulated macrophage mobility; unexpectedly, DPP4 mediated the glucocorticoid-induced macrophage migration, and siRNA-mediated knockdowns of GR and DPP4 blocked dexamethasone-induced THP1-MΦ migration. Moreover, glucocorticoid-induced DPP4 activation was also observed in proinflammatory M1-polarized murine macrophages, as well as peritoneal macrophages, and was associated with increased macrophage migration. Our results indicate that glucocorticoids directly up-regulate DPP4 expression and thereby induce migration in macrophages, potentially explaining why glucocorticoid therapy is less effective in controlling macrophage-dominated inflammatory disorders.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:295 |
---|---|
Enthalten in: |
The Journal of biological chemistry - 295(2020), 10 vom: 06. März, Seite 3213-3227 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Diaz-Jimenez, David [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 20.10.2020 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1074/jbc.RA119.010894 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM305844407 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM305844407 | ||
003 | DE-627 | ||
005 | 20231225122047.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1074/jbc.RA119.010894 |2 doi | |
028 | 5 | 2 | |a pubmed24n1019.xml |
035 | |a (DE-627)NLM305844407 | ||
035 | |a (NLM)31988243 | ||
035 | |a (PII)S0021-9258(17)49521-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Diaz-Jimenez, David |e verfasserin |4 aut | |
245 | 1 | 0 | |a Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.10.2020 | ||
500 | |a Date Revised 14.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Glucocorticoids are potent endogenous anti-inflammatory molecules, and their cognate receptor, glucocorticoid receptor (GR), is expressed in nearly all immune cells. Macrophages are heterogeneous immune cells having a central role in both tissue homeostasis and inflammation and also play a role in the pathogenesis of some inflammatory diseases. Paradoxically, glucocorticoids have only a limited efficacy in controlling the resolution of these macrophage-related diseases. Here, we report that the transcriptomes of monocyte-like THP-1 cells and macrophage-like THP-1 cells (THP1-MΦ) have largely conserved gene expression patterns. In contrast, the differentiation to THP1-MΦ significantly altered the sensitivity of gene transcription to glucocorticoids. Among glucocorticoid-regulated genes, we identified the exopeptidase dipeptidyl peptidase-4 (DPP4) as a critical glucocorticoid-responsive gene in THP1-MΦ. We found that GR directly induces DPP4 gene expression by binding to two glucocorticoid-responsive elements (GREs) within the DPP4 promoter. Additionally, we show that glucocorticoid-induced DPP4 expression is blocked by the GR antagonist RU-486 and by GR siRNA transfection and that DPP4 enzyme activity is reduced by DPP4 inhibitors. Of note, glucocorticoids highly stimulated macrophage mobility; unexpectedly, DPP4 mediated the glucocorticoid-induced macrophage migration, and siRNA-mediated knockdowns of GR and DPP4 blocked dexamethasone-induced THP1-MΦ migration. Moreover, glucocorticoid-induced DPP4 activation was also observed in proinflammatory M1-polarized murine macrophages, as well as peritoneal macrophages, and was associated with increased macrophage migration. Our results indicate that glucocorticoids directly up-regulate DPP4 expression and thereby induce migration in macrophages, potentially explaining why glucocorticoid therapy is less effective in controlling macrophage-dominated inflammatory disorders | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, N.I.H., Intramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a DPP4 inhibitors | |
650 | 4 | |a chromatin remodeling | |
650 | 4 | |a dipeptidyl peptidase-4 (DPP4) | |
650 | 4 | |a gene expression | |
650 | 4 | |a glucocorticoid | |
650 | 4 | |a glucocorticoid receptor | |
650 | 4 | |a immunology | |
650 | 4 | |a inflammation | |
650 | 4 | |a linagliptin | |
650 | 4 | |a macrophage | |
650 | 4 | |a migration | |
650 | 4 | |a nuclear receptor | |
650 | 4 | |a sitagliptin | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a RNA, Small Interfering |2 NLM | |
650 | 7 | |a Receptors, Glucocorticoid |2 NLM | |
650 | 7 | |a Linagliptin |2 NLM | |
650 | 7 | |a 3X29ZEJ4R2 |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
650 | 7 | |a DPP4 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.14.5 |2 NLM | |
650 | 7 | |a Dipeptidyl Peptidase 4 |2 NLM | |
650 | 7 | |a EC 3.4.14.5 |2 NLM | |
650 | 7 | |a Sitagliptin Phosphate |2 NLM | |
650 | 7 | |a TS63EW8X6F |2 NLM | |
700 | 1 | |a Petrillo, Maria Grazia |e verfasserin |4 aut | |
700 | 1 | |a Busada, Jonathan T |e verfasserin |4 aut | |
700 | 1 | |a Hermoso, Marcela A |e verfasserin |4 aut | |
700 | 1 | |a Cidlowski, John A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of biological chemistry |d 1945 |g 295(2020), 10 vom: 06. März, Seite 3213-3227 |w (DE-627)NLM000004995 |x 1083-351X |7 nnns |
773 | 1 | 8 | |g volume:295 |g year:2020 |g number:10 |g day:06 |g month:03 |g pages:3213-3227 |
856 | 4 | 0 | |u http://dx.doi.org/10.1074/jbc.RA119.010894 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 295 |j 2020 |e 10 |b 06 |c 03 |h 3213-3227 |